ClinicalTrials.Veeva

Menu

Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission

A

Asmaa mohammed abdelaal abdelaal

Status

Not yet enrolling

Conditions

Inflammatory Bowel Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT06691451
Thrombophilia in ibd patients

Details and patient eligibility

About

Inherited thombopllia and thrombotic risks in inflammatory bowel Disease during activity and remission

Full description

Inflammatory bowel diseases (IBD) are systemic conditions characterized by multiple intestinal and extra-intestinal manifestations related to the associated chronic inflammatory state. Among their diverse extra-intestinal complications, venous thromboembolism (VTE) remains one of the most under recognized causes of morbidity and mortality in these patients, highlighting the need for a better understanding of the underlying mechanism of hypercoagulability, in addition to the role of acquired and inherited risk factors that further increase the risk of thrombosis with its impact on patients' outcomes.[1, 2]

Enrollment

93 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age (18yrs - 65yrs) both sex

Exclusion criteria

  • Presence of acquired cause (pregnancy, recent surgery, history of drug, History of malignant Disease, History of blood or blood product transfusion in last 4 weeks)

Trial contacts and locations

0

Loading...

Central trial contact

Asmaa Mohammed Abdelaal, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems